Phase I trial of weekly bortezomib (Velcade) in the treatment of patients with refractory multiple myeloma
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 22 Jan 2009 Trial phase changed from I to II as reported by ClinicalTrials.gov.
- 22 Jan 2009 Additional lead centre and lead investigator identified as reported by ClinicalTrials.gov, last updated 22-1-2009.
- 22 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.